Prolog Ventures
73
10M
34
3.17
10
0.53
13
- Stages of investment
- Areas of investment
Summary
The leading representative office of defined VC is situated in the St Louis. The fund was located in North America if to be more exact in United States.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Prolog Ventures, startups are often financed by GBS Ventures, St. Louis Arch Angels, Fisk Ventures. The meaningful sponsors for the fund in investment in the same round are Burrill & Company, Great Spirit Ventures, Prelude Ventures, LLC. In the next rounds fund is usually obtained by GBS Ventures, Burrill & Company, Advantage Capital.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Agriculture, Health Care. Among the most popular portfolio startups of the fund, we may highlight Veran Medical Technologies, CareDox, EndoStim. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The top amount of exits for fund were in 2011. This Prolog Ventures works on 16 percentage points less the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in 2-6 deals per year. The real fund results show that this VC is 4 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2007. Despite it in 2019 the fund had an activity.
This organization was formed by Brian Clevinger, Greg Johnson, Ilya Nykin. The overall number of key employees were 5.
Investments analytics
Analytics
- Total investments
- 73
- Lead investments
- 10
- Exits
- 13
- Rounds per year
- 3.17
- Follow on index
- 0.53
- Investments by industry
- Biotechnology (51)
- Health Care (44)
- Medical Device (19)
- Medical (17)
- Food and Beverage (8) Show 36 more
- Investments by region
-
- United States (72)
- Canada (1)
- Peak activity year
- 2013
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 59M
- Group Appearance index
- 0.86
- Avg. company exit year
- 12
- Avg. multiplicator
- 2.19
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kinnos | 05 Mar 2020 | Biotechnology, Health Care, CleanTech | Early Stage Venture | 6M | United States, New York, New York |
| Zystor | 16 Dec 2004 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 8M | United States, Wisconsin, Milwaukee |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.